SYRE vs AMGN: Which Stock is Better?
Side-by-side comparison of Spyre Therapeutics Inc and Amgen Inc in 2026
SYRE
Spyre Therapeutics Inc
$73.01
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | SYRE | AMGN | Winner |
|---|---|---|---|
| Market Cap | $6.30B | $191.53B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.46 | AMGN |
| Revenue Growth | 0.0% | 0.1% | AMGN |
| Gross Margin | 0.0% | 70.8% | AMGN |
Analyze SYRE
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRE or AMGN a better investment?
Comparing SYRE and AMGN: Spyre Therapeutics Inc has a market cap of $6.30B while Amgen Inc has $191.53B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRE and AMGN?
SYRE (Spyre Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRE or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRE or AMGN?
AMGN has higher revenue growth at 0.1% vs 0.0% for SYRE.
Which company is more profitable: SYRE or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 0.0% for SYRE.
Which is the larger company: SYRE or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $191.53B compared to $6.30B for SYRE.
Should I buy SYRE or AMGN in 2026?
Both SYRE and AMGN have investment merit. SYRE trades at $73.01 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRE and AMGN stock?
Key differences: Market Cap ($6.30B vs $191.53B), P/E Ratio (N/A vs 24.6x), Revenue Growth (0.0% vs 0.1%), Gross Margin (0.0% vs 70.8%).